Literature DB >> 1696956

Characterization of an immuno-dominant variable surface antigen from pathogenic and nonpathogenic Entamoeba histolytica.

U Edman1, M A Meraz, S Rausser, N Agabian, I Meza.   

Abstract

A 125-kD surface antigen of Entamoeba histolytica is recognized by 73% of immune sera from patients with amoebic liver abscesses. Using pooled human immune sera a cDNA clone (lambda cM17) encoding this antigen (M17) has been isolated from a lambda gt11 expression library of the virulent stain E. histolytica HM1:IMSS. Monospecific antibodies, purified by binding to phage lysate of lambda cM17, and mAb FA7 reacted exclusively with the 125-kD antigen by Western blot analysis. Surface binding and cap formation are observed with patient sera, purified monospecific antiserum, and mAb FA7. Corresponding genomic clones (pBSgM17-1/2/3) were isolated by hybridization with the cDNA clone. These contained an open-reading frame of 3345 bp, which is in good agreement with the mRNA size of approximately 3.0 kb as revealed by Northern hybridization with lambda cM17. The inferred amino acid sequence predicts a 125,513 dalton protein that contains 17 potential N-linked glycosylation sites and is unusually rich in tyrosine and asparagine residues. A distinctly hydrophobic NH2-terminal region may serve as membrane anchor or signal sequence. In contrast to conservation of an immunodominant epitope recognized in pathogenic and nonpathogenic strains by monoclonal FA7 and human immune sera, amplification and sequence analysis of a 1,4000-bp fragment of this gene from a fresh nonpathogenic isolate by use of the PCR demonstrate regions of significant sequence divergence in this antigen. A 1% sequence variability among different isolates of the pathogenic strain HM1:IMSS and a 12-13% variability between pathogenic and nonpathogenic strains are revealed by comparison to published partial amino acid sequences (Tannich, E., R.D. Horstmann, J. Knobloch, and H.H. Arnold. 1989. Proc. Natl. Acad. Sci. USA. 86:5118). Some restriction enzymes were found that allowed PCR diagnosis of nonpathogenic and pathogenic isolates with the exclusion of E. histolytica-like Laredo, suggesting that a detailed study of nonpathogenic and pathogenic isolates in relation to the M17 antigen sequence will provide a basis of differentiating isolates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696956      PMCID: PMC2188528          DOI: 10.1084/jem.172.3.879

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.

Authors:  S L Reed; W E Keene; J H McKerrow; I Gigli
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

2.  Identification of human glucocorticoid receptor complementary DNA clones by epitope selection.

Authors:  C Weinberger; S M Hollenberg; E S Ong; J M Harmon; S T Brower; J Cidlowski; E B Thompson; M G Rosenfeld; R M Evans
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

3.  Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica.

Authors:  E Tannich; R D Horstmann; J Knobloch; H H Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Genomic and cDNA actin sequences from a virulent strain of Entamoeba histolytica.

Authors:  U Edman; I Meza; N Agabian
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  A fast electrophoretic isoenzyme technique for the identification of invasive and non-invasive Entamoeba histolytica and "E. histolytica-like" organisms.

Authors:  D M Moss; H M Mathews
Journal:  J Protozool       Date:  1987-08

6.  Use of monoclonal antibodies to identify, characterize, and purify a 96,000-dalton surface antigen of pathogenic Entamoeba histolytica.

Authors:  B E Torian; S A Lukehart; W E Stamm
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

7.  Insulin-like growth factor II receptor as a multifunctional binding protein.

Authors:  D O Morgan; J C Edman; D N Standring; V A Fried; M C Smith; R A Roth; W J Rutter
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

8.  Isoenzyme patterns of Entamoeba histolytica isolates from asymptomatic carriers: use of gradient acrylamide gels.

Authors:  I Meza; I M De la Garza; M A Meraz; B Gallegos; M De la Torre; M Tanimoto; A Martínez-Palomo
Journal:  Am J Trop Med Hyg       Date:  1986-11       Impact factor: 2.345

9.  Entamoeba histolytica: effect of growth conditions and bacterial associates on isoenzyme patterns and virulence.

Authors:  D Mirelman; R Bracha; A Chayen; A Aust-Kettis; L S Diamond
Journal:  Exp Parasitol       Date:  1986-08       Impact factor: 2.011

10.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

Authors:  J M Short; J M Fernandez; J A Sorge; W D Huse
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

View more
  29 in total

1.  Codon usage in pathogenic Entamoeba histolytica.

Authors:  E Tannich; R D Horstmann
Journal:  J Mol Evol       Date:  1992-03       Impact factor: 2.395

2.  Recombinant antigen-based avidin-biotin microtiter enzyme-linked immunosorbent assay for serodiagnosis of invasive amebiasis.

Authors:  B R Shenai; B L Komalam; A S Arvind; P R Krishnaswamy; P V Rao
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Transient transfection of the enteric parasite Entamoeba histolytica and expression of firefly luciferase.

Authors:  J E Purdy; B J Mann; L T Pho; W A Petri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

4.  Entamoeba histolytica sequences and their relationship with experimental liver abscesses in hamsters.

Authors:  María Del Pilar Crisóstomo-Vázquez; Enedina Jiménez-Cardoso; Carlos Arroyave-Hernández
Journal:  Parasitol Res       Date:  2005-11-11       Impact factor: 2.289

5.  Similarity between a ubiquitous promoter element in an ancient eukaryote and mammalian initiator elements.

Authors:  D V Quon; M G Delgadillo; A Khachi; S T Smale; P J Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 6.  DNA probes and PCR for diagnosis of parasitic infections.

Authors:  J B Weiss
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 7.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Differences in genomic DNA sequences between pathogenic and nonpathogenic isolates of Entamoeba histolytica identified by polymerase chain reaction.

Authors:  H Tachibana; S Ihara; S Kobayashi; Y Kaneda; T Takeuchi; Y Watanabe
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Cloning of a virulence factor of Entamoeba histolytica. Pathogenic strains possess a unique cysteine proteinase gene.

Authors:  S Reed; J Bouvier; A S Pollack; J C Engel; M Brown; K Hirata; X Que; A Eakin; P Hagblom; F Gillin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Cell surface proteins of Entamoeba histolytica.

Authors:  B J Mann; W A Petri
Journal:  Parasitol Today       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.